A one-year trial of tiotropium Respimat® plus usual therapy in COPD patients

Respiratory Medicine

Volumn 104, Issue 10, 2010, Pages 1460-1472

  Bateman, E D ^a   Tashkin, D ^b   Siafakas, N ^c   Dahl, R ^d   Towse, L ^e   Massey, D ^e   Pavia, D ^e   Zhong, N S ^f  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CRETE   (Greece)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e BOEHRINGER INGELHEIM LTD   (United Kingdom)

^f GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

COPD; Exacerbation; Spirometry; Tiotropium

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINESTERASE INHIBITOR; CORTICOSTEROID; MUCOLYTIC AGENT; PLACEBO; RESPIMAT; TIOTROPIUM BROMIDE; UNCLASSIFIED DRUG; XANTHINE DERIVATIVE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SMOKING;

AGED; BRONCHODILATOR AGENTS; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; PATIENT COMPLIANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SCOPOLAMINE DERIVATIVES; SMOKING;

EID: 77956338422     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.06.004     Document Type: Article

References (26)

1. W. Vincken, J.A. van Noord, A.P. Greefhorst, T.A. Bantje, S. Kesten, and L. Korducki Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium Eur Respir J 19 2002 209 216
2. R. Casaburi, D.A. Mahler, P.W. Jones, A. Wanner, P.G. San, and R.L. ZuWallack A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease Eur Respir J 19 2002 217 224
3. V. Brusasco, R. Hodder, M. Miravitlles, L. Korducki, L. Towse, and S. Kesten Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD Thorax 58 2003 399 404
4. B. Celli, R. ZuWallack, S. Wang, and S. Kesten Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes Chest 124 2003 1743 1748
5. D.E. O'Donnell, T. Flüge, F. Gerken, A. Hamilton, K. Webb, and B. Aguilaniu Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD Eur Respir J 23 2004 832 840
6. D.E. Niewoehner, K. Rice, C. Cote, D. Paulson, J.A. Cooper Jr., and L. Korducki Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial Ann Intern Med 143 2005 317 326
7. B. Zierenberg Optimizing the in vitro performance of Respimat J Aerosol Med 12 Suppl. 1 1999 S19 S24
8. D. Hochrainer, H. Holz, C. Kreher, L. Scaffidi, M. Spallek, and H. Wachtel Comparison of the aerosol velocity and spray duration of Respimat® Soft Mist Inhaler™ and pressurized metered dose inhalers J Aerosol Med 18 2005 273 282
9. S.P. Newman Use of gamma scintigraphy to evaluate the performance of new inhalers J Aerosol Med 12 Suppl. 1 1999 S25 S31
10. G. Pitcairn, S. Reader, D. Pavia, and S. Newman Deposition of corticosteroid aerosol in the human lung by Respimat® Soft Mist™ Inhaler compared to deposition by metered dose inhaler or by Turbuhaler® dry powder inhaler J Aerosol Med 18 2005 264 272
11. E. Bateman, D. Singh, D. Smith, B. Disse, L. Towse, and D. Massey Efficacy and safety of tiotropium Respimat® SMI in COPD in two 1-year randomised studies Int J COPD 5 2010 197 208
12. P.H. Quanjer, G.J. Tammeling, J.E. Cotes, O.F. Pedersen, R. Peslin, and J.C. Yernault Lung volumes and forced ventilatory flows. Report working party standardisation of lung function tests, European community for steel and coal. Official statement of the European respiratory society Eur Respir J 6 Suppl. 16 1993 5 40
13. P.W. Jones St George's respiratory questionnaire: MCID COPD 2 2005 75 79
14. D.P. Tashkin, B. Celli, S. Senn, D. Burkhart, S. Kesten, and S. Menjoge A 4-year trial of tiotropium in chronic obstructive pulmonary disease N Engl J Med 359 2008 1543 1554
15. J.A. van Noord, J.L. Aumann, E. Janssens, J.J. Smeets, J. Verhaert, B. Disse, A. Mueller, and P.J. Cornelissen Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD Eur Respir J 26 2005 214 222
16. C. Vogelmeier, P. Kardos, S. Harari, S.J. Gans, S. Stenglein, and J. Thirlwell Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study Respir Med 102 2008 1511 1520
17. J.A. van Noord, J.-L. Aumann, E. Janssens, J.J. Smeets, J. Zaagsma, and A. Mueller Combining tiotropium and salmeterol in COPD: effects on airflow obstruction and symptoms Respir Med 104 2010 995 1004
18. S. Kesten, M. Jara, C. Wentworth, and S. Lanes Pooled clinical trial analysis of tiotropium safety Chest 130 2006 1695 1703
19. S. Singh, Y.K. Loke, and C.D. Furberg Adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis JAMA 300 2008 1439 1450
20. R.G. Barr, J. Bourbeau, C.A. Camargo, and F.S. Ram Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis Thorax 61 2006 854 862
21. G.J. Rodrigo, J.A. Castro-Rodriguez, L.J. Nannini, V. Plaza Moral, and E.A. Schiavi Tiotropium and risk for fatal and nonfatal cardiovascular events in patients with chronic obstructive pulmonary disease: systematic review with meta-analysis Respir Med 103 10 2009 1421 1429
22. S. Kesten, B. Celli, M. Decramer, I. Leimer, and D. Tashkin Tiotropium HandiHaler in the treatment of COPD: a safety review Int J Chron Obstruct Pulmon Dis 4 2009 397 409
23. S.R. Salpeter, T.M. Ormiston, and E.E. Salpeter Cardiovascular effects of β-agonists in patients with asthma and COPD Chest 125 2004 2309 2321
24. J.A. van Noord, P.J.G. Cornelissen, J.-L. Aumann, J. Platz, A. Mueller, and C. Fogarty The efficacy of tiotropium administered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients Respir Med 103 2009 22 29
25. W. Schürmann, S. Schmidtmann, P. Moroni, D. Massey, and M. Qidan Respimat® Soft Mist™ inhaler versus hydrofluoroalkane metered dose inhaler: patient preference and satisfaction Treat Respir Med 4 2005 53 61
26. R. Hodder, and D. Price Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat® Soft Mist™ Inhaler Int J COPD 4 2009 381 390